Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating chronic obstructive pulmonary disease

A chronic obstructive, composition technology, applied in the direction of drug combination, pharmaceutical formula, plant raw materials, etc., can solve the problems of treating the symptoms but not the root cause, easy recurrence, and large side effects.

Active Publication Date: 2015-04-22
CHANGSHA BAISHUN BIOTECH
View PDF2 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although these drugs have a certain curative effect, they treat the symptoms but not the root cause, such as glucocorticoids, which are easy to relapse, easily cause iatrogenic injury, and have relatively large side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Example 1 Prescription and preparation method of composition granules of the present invention: 40 parts of raw Astragalus membranaceus, 25 parts of Poria cocos, 25 parts of Codonopsis radix, 20 parts of Scutellaria baicalensis, 10 parts of fried Atractylodes macrocephala, 10 parts of tangerine peel, 8 parts of angelica, 8 parts of bellflower, and Chuanbei 8 parts, 10 parts of roasted licorice, 4 parts of Cimicifuga, 4 parts of loquat leaves, mixed with water and decocted for 2 hours, 6 times of water addition, 2 times of decoction; combined the two filtrates, concentrated under reduced pressure to relative The density is 1.20-1.40 to obtain a water-extracted thick paste; the thick paste is dried under reduced pressure at a drying temperature of 50-80°C, and then crushed through an 80-mesh sieve to obtain an extract powder. Add an appropriate proportion of excipients to the extract powder. The excipients are intended to be sucrose or lactose (mannitol, aspartame, stevios...

Embodiment 2

[0031] Example 2 Prescription and preparation method of composition granules of the present invention: 50 parts of raw Astragalus membranaceus, 35 parts of Poria cocos, 25 parts of Codonopsis radix, 15 parts of Scutellaria baicalensis, 5 parts of fried Atractylodes macrocephala, 5 parts of tangerine peel, 8 parts of angelica, 8 parts of platycodon, Chuanbei 8 parts, 10 parts of roasted licorice, 4 parts of Cimicifuga, 4 parts of loquat leaves, mixed with water and decocted for 2 hours, 6 times of water addition, 2 times of decoction; combined the two filtrates, concentrated under reduced pressure to relative The density is 1.20-1.40 to obtain a water-extracted thick paste; the thick paste is dried under reduced pressure at a drying temperature of 50-80°C, and then crushed through an 80-mesh sieve to obtain an extract powder. Add an appropriate proportion of excipients to the extract powder. The excipients are intended to be sucrose or lactose (mannitol, aspartame, stevioside fo...

Embodiment 3

[0032] Example 3 Prescription and preparation method of composition granules of the present invention: 40 parts of raw Astragalus membranaceus, 25 parts of Poria cocos, 25 parts of Codonopsis radix, 20 parts of Scutellaria baicalensis, 10 parts of fried Atractylodes macrocephala, 10 parts of tangerine peel, 8 parts of angelica, 8 parts of bellflower, and Chuanbei 8 parts, 10 parts of roasted licorice, 4 parts of Cimicifuga, 4 parts of loquat leaves, mixed with water and decocted twice, the first decoction was 3 hours, and the multiple of water was 8 times, and the second decoction was 2 hours, and the multiple of water was 6 times; The two filtrates are combined, concentrated under reduced pressure to a relative density of 1.20-1.40 to obtain a water extract thick paste; the thick paste is dried under reduced pressure at a drying temperature of 50-80°C, and then crushed through an 80-mesh sieve to obtain an extract powder . Add an appropriate proportion of excipients to the ex...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pharmaceutical composition for treating chronic obstructive lung disease. The pharmaceutical composition is characterized in that the prescription of the pharmaceutical composition contains the ingredients in parts by weight: 10-60 parts of raw milkvetch root, 10-35 parts of poria cocos, 10-30 parts of codonopsis pilosula, 10-35 parts of scutellaria root, 5-18 parts of fried atractylodes macrocephala, 5-18 parts of dried tangerine peel, 5-18 parts of angelica sinensis, 5-18 parts of balloon flower root, 5-15 parts of bulbus fritilariae, 5-15 parts of prepared liquorice root, 1-7 parts of rhizoma cimicifugae and 1-7 parts of loquat leaves. The pharmaceutical composition preparation is prepared from a traditional Chinese medicine composition and a pharmaceutically-acceptable carrier, and dosage forms comprise decoction, pills, capsules, granules, dissolved granules, tablets and oral liquid. The composition provided by the invention has the effects of invigorating the spleen to benefit the lung and resolving phlegm and dredging the collaterals, has a remarkable treatment effect on patients suffering from chronic obstructive pulmonary disease, and is free from toxic or side effects.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine preparations, in particular to a pharmaceutical composition for treating chronic obstructive pulmonary disease. Background technique [0002] Chronic obstructive pulmonary disease (COPD) is a destructive lung disease characterized by airflow limitation that is not fully reversible, usually progressive and harmful to the lungs Associated with an abnormal inflammatory response to particles or gases. COPD is a chronic airway inflammatory disease that can be prevented and treated. Although COPD is an airway disease, its systemic impact on the whole body cannot be ignored. Infection is one of the important factors for the occurrence and development of COPD. Viruses, bacteria and mycoplasma are important factors for the acute exacerbation of the disease. The viruses are mainly influenza virus, rhinovirus, adenovirus and respiratory syncytial virus, etc. Bacterial infections include Streptoco...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8966A61P11/00
CPCA61K9/0095A61K9/1623A61K9/1652A61K36/076A61K36/232A61K36/284A61K36/34A61K36/344A61K36/481A61K36/484A61K36/539A61K36/71A61K36/73A61K36/752A61K36/8966A61K2236/331A61K2236/39A61K2236/51A61K2300/00
Inventor 不公告发明人
Owner CHANGSHA BAISHUN BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com